Acyclic cucurbit[n]uril molecular containers enhance the solubility and bioactivity of poorly soluble pharmaceuticals. - Wikidata - wikimedia - TriplyDB

Acyclic cucurbit[n]uril molecular containers enhance the solubility and bioactivity of poorly soluble pharmaceuticals.

Acyclic cucurbit[n]uril molecular containers enhance the solubility and bioactivity of poorly soluble pharmaceuticals.

http://www.wikidata.org/entity/Q39344797

about

Supramolecular Complexation of Carbohydrates for the Bioavailability Enhancement of Poorly Soluble Drugs Acyclic CB[n]-type molecular containers: effect of solubilizing group on their function as solubilizing excipients.Stimuli responsive systems constructed using cucurbit[n]uril-type molecular containers.A pillararene-based ternary drug-delivery system with photocontrolled anticancer drug release.Complexation and Catenation in Aqueous Media Using a Self-Assembled Pd(II) Metallacyclic Receptor.Acyclic Cucurbit[n]uril-Type Molecular Containers: Influence of Linker Length on Their Function as Solubilizing Agents.Uptake of Hydrocarbons in Aqueous Solution by Encapsulation in Acyclic Cucurbit[n]uril-Type Molecular Containers.Glycoluril-Derived Molecular Clips are Potent and Selective Receptors for Cationic Dyes in Water.Molecular Recognition Properties of Biphen[4]arene.Self-assembly of dinuclear Pd(ii)/Pt(ii) metallacyclic receptors incorporating N-heterocyclic carbene complexes as corners.Biphen[n]arenes Labeled protein recognition at a membrane bilayer interface by embedded synthetic receptors.New small-molecule inhibitors effectively blocking picornavirus replication Synthesis and self-assembly processes of monofunctionalized cucurbit[7]uril.The ex vivo neurotoxic, myotoxic and cardiotoxic activity of cucurbituril-based macrocyclic drug delivery vehicles.Acyclic cucurbit[n]uril-type molecular containers: influence of aromatic walls on their function as solubilizing excipients for insoluble drugs.Strong cation···π interactions promote the capture of metal ions within metal-seamed nanocapsule.Protocols utilizing constant pH molecular dynamics to compute pH-dependent binding free energies Acyclic cucurbit[n]uril-type molecular containers: influence of glycoluril oligomer length on their function as solubilizing agents.A simple assay for quality binders to cucurbiturils.Synthesis of a Disulfonated Derivative of Cucurbit[7]uril and Investigations of its Ability to Solubilize Insoluble Drugs.Sustained Small Molecule Delivery from Injectable Hyaluronic Acid Hydrogels through Host-Guest Mediated Retention Highly efficient complexation of sanguinarine alkaloid by carboxylatopillar[6]arene: pKa shift, increased solubility and enhanced antibacterial activity.In Vitro selectivity of an acyclic cucurbit[n]uril molecular container towards neuromuscular blocking agents relative to commonly used drugs.On the Role of Dewetting Transitions in Host-Guest Binding Free Energy Calculations.Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors Variational Implicit-Solvent Modeling of Host-Guest Binding: A Case Study on Cucurbit[7]uril|Cationic acyclic cucurbit[n]uril-type containers: synthesis and molecular recognition toward nucleotides.Cucurbit[7]uril containers for targeted delivery of oxaliplatin to cancer cells Variational Implicit Solvation with Poisson-Boltzmann Theory.Co-grinding Effect on Crystalline Zaltoprofen with β-cyclodextrin/Cucurbit[7]uril in Tablet Formulation.Host-guest supramolecular nanosystems for cancer diagnostics and therapeutics.Cucurbit[n]uril type hosts for the reversal of steroidal neuromuscular blocking agents.A naphthalimide derived fluorescent sensor for solid-phase screening of cucurbit[7]uril-guest interactions.Drug delivery by supramolecular design.Stabilization of reactive species by supramolecular encapsulation.Reversing neuromuscular blockade: inhibitors of the acetylcholinesterase versus the encapsulating agents sugammadex and calabadion.Synthesis and separation of cucurbit[n]urils and their derivatives.Covalent bond or noncovalent bond: a supramolecular strategy for the construction of chemically synthesized vaccines.Practical applications of supramolecular chemistry.

P2860

Q26777831-6AF6B0DD-71C2-4D6D-81EF-81923C20339E Q30770195-C4459B41-83DD-4C85-9166-CFD2FAE8A087 Q30812330-9ECB0A42-BEB0-4998-B62A-652BC67B1E63 Q30860444-7FD1CD02-C5F5-4FD9-B7EA-7B6DC39AC6BE Q30963102-331516D1-0981-4677-BDB9-D11C05C051DD Q31060481-2EE27648-78A2-47EA-AC21-88948A997361 Q31095509-6310F7EE-558A-4474-8372-9BB00B6752CA Q31119698-B2DBCD75-8513-48BB-AB42-36D4CAADF700 Q31137718-BAFDCED7-7AF1-46D4-92E0-A02EDDEF496A Q31171348-B22AA108-1F52-43B6-8A39-22CEB16F52EE Q33656011-6BBD5B3C-D877-4C6F-A666-0C6EA408E58A Q34249800-1433C31C-C999-4A7C-A67E-5269451AB697 Q34261753-3855447B-D4E6-4C9A-952B-BE777C254BA1 Q34338553-332550F7-E9CC-4ECB-AD7E-7E0BF8721D7D Q34523282-27FDB4E4-59B6-42FC-9088-CB613C6E73BA Q34631587-75893B1A-00A8-4F1D-B307-55B2F246CB16 Q34778248-627EEB88-93D9-4410-AC71-8AC176FD02EA Q35013427-74F90EE4-B150-4B74-98B5-52120B532A89 Q35196330-B49A2259-0021-4369-939C-FA061E325520 Q35209831-4BBBEF83-5AC2-4857-A0EC-4E1BCF0061E1 Q35546753-AFE030DF-EE45-4631-ADE9-E87D1EDBACF6 Q36362400-F9CF5BDF-3231-4F6F-B13D-9694EA0B0C2A Q36405116-B498BA26-E2D7-47D1-8588-09F008CC3C1F Q36483980-06FD2930-E9BD-4C50-B43F-0B4F07780ED5 Q36523088-8AFDBD98-4AA2-47A4-BCCE-22F068141CC6 Q36665183-06EA9C6A-47E1-47BC-A781-C73E5543A293 Q37162960-83F1F471-6EC1-4F64-8E8D-974D78E5604C Q37337547-A8BED874-66B6-406B-9C6F-7CD702EB5616 Q37638514-6F60A71B-9FCC-44DA-8AE6-E3A08266DD8B Q37701462-0D5965AC-A6A7-451A-AD2B-6A950F3B9C11 Q37734910-BF97E61B-80BA-4FBB-9A97-562D3157948F Q38139328-784CB33E-D626-4C87-9A00-CC9D105A8414 Q38161549-F352C470-7F7F-4EEF-A90D-0ACB443AD8F9 Q38543431-8D7B491C-2CFE-4653-8F4A-1CAA6F7FABBC Q38638945-CED6191E-9EEC-4079-BFA1-AFE802F7BED8 Q38707091-558EF283-2859-4B1B-A46C-BE4926B410B9 Q38707992-6304A8C1-CC1E-41FC-B1BA-21597F13A464 Q38780166-8B2CB007-DE39-4292-8668-DCF416542452 Q38962995-E5640854-AD5D-4E5C-9BBC-C161496041CE Q39186762-0E990449-5284-4BE2-B1DF-D12EE765D4C1

P2860

Acyclic cucurbit[n]uril molecular containers enhance the solubility and bioactivity of poorly soluble pharmaceuticals.

http://www.wikidata.org/entity/Q39344797

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Acyclic cucurbit[n]uril molecu ...... oorly soluble pharmaceuticals.

@en

Acyclic cucurbit[n]uril molecu ...... oorly soluble pharmaceuticals.

@nl

type

label

Acyclic cucurbit[n]uril molecu ...... oorly soluble pharmaceuticals.

@en

Acyclic cucurbit[n]uril molecu ...... oorly soluble pharmaceuticals.

@nl

prefLabel

Acyclic cucurbit[n]uril molecu ...... oorly soluble pharmaceuticals.

@en

Acyclic cucurbit[n]uril molecu ...... oorly soluble pharmaceuticals.

@nl

P1433

Q39344797-C7EF07CF-D372-43E9-92AC-542DDDB932DD

P1476

Q39344797-DD88F8B3-3ECD-407C-8955-64ED0D739090

P2093

Q39344797-2EC4E07A-5500-427F-AE6F-2216FAA373FC

Q39344797-4A99B293-662B-427D-8F92-81AC02959CB2

Q39344797-6B7E23A7-9056-4C3A-B8F2-DE8015CBC1BF

Q39344797-92933585-D140-4915-B6F3-28E537B4A977

Q39344797-ED454D46-0FF6-493E-B76B-B9E57D81A60E

P2860

Q39344797-025B44DC-9038-4433-B6C6-D2672E000886

Q39344797-121F2E9F-0306-4AEE-8D51-CB4C26E708F8

Q39344797-156F167A-A2AC-496E-849C-26B2D580B48A

Q39344797-1FB90302-DCC7-46B0-9DBF-E50EB21BE185

Q39344797-22359BB6-7431-4C51-AD5B-8AC56D87858B

Q39344797-29E18BA6-9D36-49CF-8995-FF2ACE624AD1

Q39344797-3ABA1900-347D-40D5-8A5B-741C851B78CA

Q39344797-42E5A183-2D40-4902-B5D0-45278F85483B

Q39344797-495CAE5C-A5E7-4A5D-88E7-597F204C8FD3

Q39344797-5CCC4D20-C700-492F-BB02-AE5A11023E7F

P2888

Q39344797-40E1C590-26DB-435F-AB8A-7282FEF49ECB

P304

Q39344797-A7E3A4AA-2E2E-471D-B5B7-A24735282111

P31

Q39344797-FB655CF3-31B6-4791-B905-A7930792AE09

P356

Q39344797-5D2BE05F-ECA5-4EDB-B088-E6EE30B57415

P433

Q39344797-30E7936B-3DCF-4454-BC74-7128F3150445

P478

Q39344797-02551C81-0429-4F64-B40F-A36D98BF2FD1

P50

Q39344797-E71B3CF8-2CA2-4420-BEEF-B9E9B0866282

Q39344797-F39022FD-1DD0-4098-91DD-85AEDB9FFBB5

Q39344797-FCD202EB-C85B-4675-97B6-96C6AEE63836

P577

Q39344797-F58EBE14-4928-4B65-A5BB-98C72A2D6BFB

P5875

Q39344797-43D36959-9D2D-4DA3-83F7-27ECBB6186E7

P6179

Q39344797-7DF6BAF1-BED3-401A-984A-79FCF51EE84B

P698

Q39344797-6D1D1302-C311-4ABE-88C9-990EF4172A6D

P356

P1433

Nature Chemistry

P1476

Acyclic cucurbit[n]uril molecu ...... oorly soluble pharmaceuticals.

@en

P2093

Ben Zhang

http://www.w3.org/2001/XMLSchema#string

Da Ma

http://www.w3.org/2001/XMLSchema#string

Duc Nguyen

http://www.w3.org/2001/XMLSchema#string

Gaya Hettiarachchi

http://www.w3.org/2001/XMLSchema#string

James B Wittenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles

Toxicology and drug delivery by cucurbit[n]uril type molecular containers

Synthetic Molecular Motors and Mechanical Machines

Drug-like properties and the causes of poor solubility and poor permeability.

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation.

Enhanced cytotoxicity of benzimidazole carbamate derivatives and solubilisation by encapsulation in cucurbit[n]uril.

Mechanisms of drug release from cyclodextrin complexes.

Improving drug solubility for oral delivery using solid dispersions.

Artificial Molecular Machines.

Kinetic resolution of constitutional isomers controlled by selective protection inside a supramolecular nanocapsule.

P2888

P304

503-510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCHEM.1326

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225053570

http://www.w3.org/2001/XMLSchema#string

P6179

1043473750

http://www.w3.org/2001/XMLSchema#string

P698

22614387

http://www.w3.org/2001/XMLSchema#string